Delivery Order SPE2DB22D3004-SPE2DB24FNL76
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Victoza 3-Pak 18 mg/3 ml pen, a medication used to treat diabetes. The delivery order contract is valued at $6,404.26 and has a completion date of October 6, 2023. The contract is a firm fixed-price, delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,966.32 delivery order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used to treat diabetes. The contract has an ultimate completion date of August 31, 2022 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,080.29 delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialized medication used for diabetes management. The contract has a firm fixed price pricing type and a period of performance through November 25, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,437.62, is a delivery order for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. The contract has an ultimate completion date of May 30, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,371.32, is for the delivery of Victoza 2-pak 18 mg/3 ml pen 3ml, a medication used to treat type 2 diabetes. The contract was awarded on September 16, 2021, with a completion date of September 17, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,970.71 firm fixed-price delivery order is for the supply of Victoza 2-Pak 18 mg/3 ml pens, a medication used for the treatment of type 2 diabetes. The contract has an ultimate completion date of January 24, 2024 and was awarded on January 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $12,461.42, is a delivery order for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a medication used in the treatment of diabetes. The contract has a firm fixed price structure and an ultimate completion date of September 10, 2024. AmerisourceBergen, as the prime contractor, will be responsible for...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is a Delivery Order valued at $6,339.72 for the procurement of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medical product used for diabetes management. The contract has an ultimate completion date of December 24, 2024 and is a Firm Fixed Price agreement. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.12 fixed-price delivery order is for the procurement of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $2,056.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used for diabetes management. The contract has an ultimate completion date of November 22, 2023 and is a Firm Fixed Price arrangement. This award is not designated as a set-aside contract....
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FNL76Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,847.54, is a delivery order for the supply of Victoza 3-Pak 18 mg/3 ml Pen 3 ml, a medication used for the treatment of type 2 diabetes. The contract has an ultimate completion date of November 16, 2023 and is designated as a firm fixed-price contract. No set-aside requirements were used for this award. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 11/15/23 |